• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清 Mir-150-3p 表达增加与 COVID-19 患者肺部放射学损伤改善相关。

Increased Serum Mir-150-3p Expression Is Associated with Radiological Lung Injury Improvement in Patients with COVID-19.

机构信息

Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas 13083-887, SP, Brazil.

Department of Clinical Pathology, School of Medical Sciences, University of Campinas, Campinas 13083-887, SP, Brazil.

出版信息

Viruses. 2022 Jun 23;14(7):1363. doi: 10.3390/v14071363.

DOI:10.3390/v14071363
PMID:35891345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9323362/
Abstract

Coronavirus disease 2019 (COVID-19) is caused by the SARS-CoV-2 virus, responsible for an atypical pneumonia that can progress to acute lung injury. MicroRNAs are small non-coding RNAs that control specific genes and pathways. This study evaluated the association between circulating miRNAs and lung injury associated with COVID-19. We evaluated lung injury by computed tomography at hospital admission and discharge and the serum expression of 754 miRNAs using the TaqMan OpenArray after hospital discharge in 27 patients with COVID-19. In addition, miR-150-3p was validated by qRT-PCR on serum samples collected at admission and after hospital discharge. OpenArray analysis revealed that seven miRNAs were differentially expressed between groups of patients without radiological lung improvement compared to those with lung improvement at hospital discharge, with three miRNAs being upregulated (miR-548c-3p, miR-212-3p, and miR-548a-3p) and four downregulated (miR-191-5p, miR-151a-3p, miR-92a-3p, and miR-150-3p). Bioinformatics analysis revealed that five of these miRNAs had binding sites in the SARS-CoV-2 genome. Validation of miR-150-3p by qRT-PCR confirmed the OpenArray results. The present study shows the potential association between the serum expression of seven miRNAs and lung injury in patients with COVID-19. Furthermore, increased expression of miR-150 was associated with pulmonary improvement at hospital discharge.

摘要

新型冠状病毒病(COVID-19)由 SARS-CoV-2 病毒引起,可引起非典型性肺炎,并进展为急性肺损伤。微小 RNA(miRNA)是一种小的非编码 RNA,可以控制特定的基因和通路。本研究评估了循环 miRNA 与 COVID-19 相关肺损伤之间的关联。我们通过入院时和出院时的计算机断层扫描(CT)评估肺损伤,并在出院后使用 TaqMan OpenArray 检测 27 例 COVID-19 患者的血清中 754 个 miRNA 的表达。此外,还通过 qRT-PCR 在入院和出院后收集的血清样本中验证了 miR-150-3p。OpenArray 分析显示,与出院时肺部改善的患者相比,肺部影像学无改善的患者之间有七个 miRNA 表达存在差异,其中三个 miRNA 上调(miR-548c-3p、miR-212-3p 和 miR-548a-3p),四个下调(miR-191-5p、miR-151a-3p、miR-92a-3p 和 miR-150-3p)。生物信息学分析显示,这五个 miRNA 中有五个在 SARS-CoV-2 基因组中有结合位点。通过 qRT-PCR 验证 miR-150-3p 进一步证实了 OpenArray 的结果。本研究表明,COVID-19 患者血清中七种 miRNA 的表达与肺损伤之间存在潜在关联。此外,miR-150 的表达增加与出院时肺部改善相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a421/9323362/e27f0d839182/viruses-14-01363-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a421/9323362/5c64ade59752/viruses-14-01363-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a421/9323362/08b70dd282fa/viruses-14-01363-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a421/9323362/941aa3178eb3/viruses-14-01363-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a421/9323362/e27f0d839182/viruses-14-01363-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a421/9323362/5c64ade59752/viruses-14-01363-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a421/9323362/08b70dd282fa/viruses-14-01363-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a421/9323362/941aa3178eb3/viruses-14-01363-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a421/9323362/e27f0d839182/viruses-14-01363-g004.jpg

相似文献

1
Increased Serum Mir-150-3p Expression Is Associated with Radiological Lung Injury Improvement in Patients with COVID-19.血清 Mir-150-3p 表达增加与 COVID-19 患者肺部放射学损伤改善相关。
Viruses. 2022 Jun 23;14(7):1363. doi: 10.3390/v14071363.
2
A new insight into sex-specific non-coding RNAs and networks in response to SARS-CoV-2.对 SARS-CoV-2 反应中性别特异性非编码 RNA 及网络的新认识。
Infect Genet Evol. 2022 Jan;97:105195. doi: 10.1016/j.meegid.2021.105195. Epub 2021 Dec 23.
3
Differential microRNA expression in the peripheral blood from human patients with COVID-19.COVID-19 患者外周血中的差异 microRNA 表达。
J Clin Lab Anal. 2020 Oct;34(10):e23590. doi: 10.1002/jcla.23590. Epub 2020 Sep 22.
4
Differentially expressed plasmatic microRNAs in Brazilian patients with Coronavirus disease 2019 (COVID-19): preliminary results.巴西 2019 冠状病毒病(COVID-19)患者血浆差异表达的 microRNAs:初步结果。
Mol Biol Rep. 2022 Jul;49(7):6931-6943. doi: 10.1007/s11033-022-07338-9. Epub 2022 Mar 17.
5
Expression Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2.SARS-CoV-2 感染仓鼠肺组织中 microRNAs 的表达分析。
Mol Cells. 2020 Nov 30;43(11):953-963. doi: 10.14348/molcells.2020.0177.
6
Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19.与血栓形成相关的循环 miR-16-5p 与因 COVID-19 住院的患者的疾病严重程度相关。
RNA Biol. 2022 Jan;19(1):963-979. doi: 10.1080/15476286.2022.2100629.
7
Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.从血清外泌体 microRNAs 中鉴定慢性萎缩性胃炎的非侵入性生物标志物。
BMC Cancer. 2019 Feb 8;19(1):129. doi: 10.1186/s12885-019-5328-7.
8
Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients.与 COVID-19 患者疾病严重程度和预后相关的循环 microRNA 特征。
Front Immunol. 2022 Aug 11;13:968991. doi: 10.3389/fimmu.2022.968991. eCollection 2022.
9
SARS-COV-2 as potential microRNA sponge in COVID-19 patients.SARS-CoV-2 作为 COVID-19 患者中的潜在 miRNA 海绵。
BMC Med Genomics. 2022 Apr 23;15(Suppl 2):94. doi: 10.1186/s12920-022-01243-7.
10
Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.血清 microRNA 芯片分析鉴定出 miR-140-3p、miR-33b-3p 和 miR-671-3p 作为潜在的与代谢过程相关的骨关节炎生物标志物。
Clin Epigenetics. 2017 Dec 12;9:127. doi: 10.1186/s13148-017-0428-1. eCollection 2017.

引用本文的文献

1
Identification of miRNAs that target Fcγ receptor-mediated phagocytosis during macrophage activation syndrome.鉴定巨噬细胞活化综合征中靶向 Fcγ 受体介导的吞噬作用的 microRNAs。
Front Immunol. 2024 Mar 15;15:1355315. doi: 10.3389/fimmu.2024.1355315. eCollection 2024.
2
LncRNA-mediated ceRNA network reveals the mechanism of action of Saorilao-4 decoction against pulmonary fibrosis.长链非编码RNA介导的竞争性内源RNA网络揭示了扫日劳-4汤抗肺纤维化的作用机制。
Front Genet. 2024 Mar 12;15:1339064. doi: 10.3389/fgene.2024.1339064. eCollection 2024.

本文引用的文献

1
Profiling Levels of Serum microRNAs and Soluble ACE2 in COVID-19 Patients.新型冠状病毒肺炎患者血清微小核糖核酸和可溶性血管紧张素转换酶2水平分析
Life (Basel). 2022 Apr 12;12(4):575. doi: 10.3390/life12040575.
2
Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review).宿主细胞进入介体参与 SARS-CoV-2 的细胞嗜性、COVID-19 的病理生理学以及鉴定可调节这些介体表达的 microRNAs(综述)。
Int J Mol Med. 2022 Feb;49(2). doi: 10.3892/ijmm.2021.5075. Epub 2021 Dec 22.
3
Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating gene.
细胞 miR-150-5p 通过调控基因,可能在 SARS-CoV-2 感染的生物学中发挥关键作用。
RNA Biol. 2022;19(1):1-11. doi: 10.1080/15476286.2021.2010959. Epub 2021 Dec 31.
4
The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review.微小 RNA 在解决新冠病毒感染到治疗的谜题中的作用:一篇迷你综述。
Virus Res. 2022 Jan 15;308:198631. doi: 10.1016/j.virusres.2021.198631. Epub 2021 Nov 14.
5
Exosomal miR-150 partially attenuated acute lung injury by mediating microvascular endothelial cells and MAPK pathway.外泌体 miR-150 通过调控微血管内皮细胞及 MAPK 通路部分减轻急性肺损伤。
Biosci Rep. 2022 Jan 28;42(1). doi: 10.1042/BSR20203363.
6
Footprints of microRNAs in Cancer Biology.癌症生物学中微小RNA的印记
Biomedicines. 2021 Oct 19;9(10):1494. doi: 10.3390/biomedicines9101494.
7
Potential Therapeutic Effect of Micrornas in Extracellular Vesicles from Mesenchymal Stem Cells against SARS-CoV-2.微小 RNA 在外泌体中的潜在治疗作用来自间充质干细胞对 SARS-CoV-2 的影响。
Cells. 2021 Sep 12;10(9):2393. doi: 10.3390/cells10092393.
8
Recognized and Potentially New Biomarkers-Their Role in Diagnosis and Prognosis of Cardiovascular Disease.识别和潜在的新生物标志物-它们在心血管疾病诊断和预后中的作用。
Medicina (Kaunas). 2021 Jul 8;57(7):701. doi: 10.3390/medicina57070701.
9
Circulating miRNAs: Potential diagnostic role for coronavirus disease 2019 (COVID-19).循环 miRNA:新型冠状病毒肺炎(COVID-19)的潜在诊断作用。
Infect Genet Evol. 2021 Oct;94:105020. doi: 10.1016/j.meegid.2021.105020. Epub 2021 Jul 31.
10
Circulating Soluble ACE2 and Upstream microRNA Expressions in Serum of Type 2 Diabetes Mellitus Patients.2 型糖尿病患者血清中可溶性 ACE2 和上游 microRNA 的表达。
Int J Mol Sci. 2021 May 17;22(10):5263. doi: 10.3390/ijms22105263.